Atreca (BCEL) Stock Forecast, Price Target & Predictions


OverviewOwnershipChart

BCEL Stock Forecast


Atreca stock forecast is as follows: an average price target of $4.00 (represents a 4344.44% upside from BCEL’s last price of $0.09) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

BCEL Price Target


The average price target for Atreca (BCEL) is $4.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $4.00 to $4.00. This represents a potential 4344.44% upside from BCEL's last price of $0.09.

BCEL Analyst Ratings


Buy

According to 1 Wall Street analysts, Atreca's rating consensus is 'Buy'. The analyst rating breakdown for BCEL stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Atreca Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 15, 2022-Wedbush$4.00$1.48171.19%4344.44%
Row per page
Go to

The latest Atreca stock forecast, released on Nov 15, 2022 by Wedbush company, set a price target of $4.00, which represents a 171.19% increase from the stock price at the time of the forecast ($1.48), and a 4344.44% increase from BCEL last price ($0.09).

Atreca Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.09$0.09$0.09
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Atreca stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Atreca's last price of $0.09. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Nov 15, 2022WedbushOutperformOutperformHold
Row per page
Go to

Atreca's last stock rating was published by Wedbush on Nov 15, 2022. The company gave BCEL a "Outperform" rating, the same as its previous rate.

Atreca Financial Forecast


Atreca Revenue Forecast

Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Dec 20
Revenue-------
Avg Forecast$59.77K$63.36K$67.16K$71.19K$75.47K$80.00K$216.67K
High Forecast$59.77K$63.36K$67.16K$71.19K$75.47K$80.00K$216.67K
Low Forecast$59.77K$63.36K$67.16K$71.19K$75.47K$80.00K$216.67K
# Analysts1111111
Surprise %-------

Atreca's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. BCEL's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Atreca EBITDA Forecast

Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Dec 20
# Analysts1111111
EBITDA------$-22.43M
Avg Forecast$-35.86K$-38.01K$-40.30K$-42.72K$-45.28K$-48.00K$-130.00K
High Forecast$-35.86K$-38.01K$-40.30K$-42.72K$-45.28K$-48.00K$-130.00K
Low Forecast$-35.86K$-38.01K$-40.30K$-42.72K$-45.28K$-48.00K$-130.00K
Surprise %------172.57%

undefined analysts predict BCEL's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Atreca's previous annual EBITDA (undefined) of $NaN.

Atreca Net Income Forecast

Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Dec 20
# Analysts1111111
Net Income------$-23.01M
Avg Forecast$-9.44M$-8.23M$-8.62M$-10.41M$-13.77M$-14.79M$-25.46M
High Forecast$-9.44M$-8.23M$-8.62M$-10.41M$-13.22M$-14.79M$-25.46M
Low Forecast$-9.44M$-8.23M$-8.62M$-10.41M$-13.77M$-14.79M$-25.46M
Surprise %------0.90%

Atreca's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BCEL's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Atreca SG&A Forecast

Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Dec 20
# Analysts1111111
SG&A------$6.64M
Avg Forecast$1.29M$1.36M$1.45M$1.53M$1.62M$1.72M$4.66M
High Forecast$1.29M$1.36M$1.45M$1.53M$1.62M$1.72M$4.66M
Low Forecast$1.29M$1.36M$1.45M$1.53M$1.62M$1.72M$4.66M
Surprise %------1.42%

Atreca's average Quarter SG&A projection for Sep 23 is $1.72M, based on 1 Wall Street analysts, with a range of $1.72M to $1.72M. The forecast indicates a -74.07% fall compared to BCEL last annual SG&A of $6.64M (Dec 20).

Atreca EPS Forecast

Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Dec 20
# Analysts1111111
EPS------$-0.62
Avg Forecast$-0.24$-0.21$-0.22$-0.26$-0.35$-0.38$-0.65
High Forecast$-0.24$-0.21$-0.22$-0.26$-0.34$-0.38$-0.65
Low Forecast$-0.24$-0.21$-0.22$-0.26$-0.35$-0.38$-0.65
Surprise %------0.97%

According to undefined Wall Street analysts, Atreca's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BCEL previous annual EPS of $NaN (undefined).

Atreca Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
BCELAtreca$0.09$4.004344.44%Buy
PASGPassage Bio$0.60$6.00900.00%Buy
BDTXBlack Diamond Therapeutics$2.99$14.75393.31%Buy
FIXXQ32 Bio$0.93$2.70190.32%Buy
STOKStoke Therapeutics$13.10$30.60133.59%Buy
RVMDRevolution Medicines, Inc. Warrant$55.87$58.574.83%Buy

BCEL Forecast FAQ


Yes, according to 1 Wall Street analysts, Atreca (BCEL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BCEL's total ratings.

Atreca (BCEL) average price target is $4 with a range of $4 to $4, implying a 4344.44% from its last price of $0.09. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for BCEL stock, the company can go up by 4344.44% (from the last price of $0.09 to the average price target of $4), up by 4344.44% based on the highest stock price target, and up by 4344.44% based on the lowest stock price target.

BCEL's average twelve months analyst stock price target of $4 supports the claim that Atreca can reach $0 in the near future.

Atreca's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $155.47K (high $155.47K, low $155.47K), average EBITDA is $-93.28K (high $-93.28K, low $-93.28K), average net income is $-28.56M (high $-28.009M, low $-28.56M), average SG&A $3.35M (high $3.35M, low $3.35M), and average EPS is $-0.726 (high $-0.712, low $-0.726). BCEL's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $261.48K (high $261.48K, low $261.48K), average EBITDA is $-157K (high $-157K, low $-157K), average net income is $-36.711M (high $-36.711M, low $-36.711M), average SG&A $5.63M (high $5.63M, low $5.63M), and average EPS is $-0.933 (high $-0.933, low $-0.933).